Criteria for selection and application of molecular markers for clinical studies of osteoarthritis
Open Access
- 1 March 2003
- journal article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 11 (3), 153-158
- https://doi.org/10.1016/s1063-4584(02)00350-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Collagen type II C-telopeptide fragments as an index of cartilage degradationBone, 2001
- An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical end-pointsOsteoarthritis and Cartilage, 2001
- An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baselineOsteoarthritis and Cartilage, 2000
- Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseasesArthritis & Rheumatism, 2000
- Validation of immunoassays for bioanalysis: a pharmaceutical industry perspectiveJournal of Pharmaceutical and Biomedical Analysis, 1999
- Inhibition of Articular Cartilage Degradation in Culture by a Novel Nonpeptidic Matrix Metalloproteinase InhibitorAnnals of the New York Academy of Sciences, 1999
- Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalitiesOsteoarthritis and Cartilage, 1998
- 5 What is the current status of biochemical markers in the diagnosis, prognosis and monitoring of osteoarthritis?Bailliere's Clinical Rheumatology, 1997
- Indexes of Severity for Osteoarthritis of the Hip and Knee:Validation–Value in Comparison with Other Assessment TestsScandinavian Journal of Rheumatology, 1987
- A Comparative Study of Various Tests for NormalityJournal of the American Statistical Association, 1968